Determines the relationship between human papillomavirus type 16 (HPV16) virus-like particles (VLP) immunoglobulin G (IgG) reactivity, viral clearance or persistence, and the course of disease in patients with premalignant cervical lesions. IgG reactivity to HPV16 VLPs in relation to HPV infection patterns; VLP IgG reactivity in relation to disease status.